- Home
- PGEN vs DCGO Comparison
PGEN vs DCGO Comparison
Compare PGEN & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- DCGO
- Stock Information
- Founded
- PGEN 1998
- DCGO 2015
- Country
- PGEN United States
- DCGO United States
- Employees
- PGEN N/A
- DCGO N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- DCGO Managed Health Care
- Sector
- PGEN Health Care
- DCGO Health Care
- Exchange
- PGEN Nasdaq
- DCGO Nasdaq
- Market Cap
- PGEN 248.7M
- DCGO 327.4M
- IPO Year
- PGEN N/A
- DCGO N/A
- Fundamental
- Price
- PGEN $0.91
- DCGO $3.39
- Analyst Decision
- PGEN Buy
- DCGO Strong Buy
- Analyst Count
- PGEN 5
- DCGO 5
- Target Price
- PGEN $7.00
- DCGO $6.10
- AVG Volume (30 Days)
- PGEN 749.9K
- DCGO 502.1K
- Earning Date
- PGEN 11-07-2024
- DCGO 11-04-2024
- Dividend Yield
- PGEN N/A
- DCGO N/A
- EPS Growth
- PGEN N/A
- DCGO 393.09
- EPS
- PGEN N/A
- DCGO 0.28
- Revenue
- PGEN $4,389,000.00
- DCGO $742,836,424.00
- Revenue This Year
- PGEN N/A
- DCGO $1.17
- Revenue Next Year
- PGEN $211.35
- DCGO N/A
- P/E Ratio
- PGEN N/A
- DCGO $12.28
- Revenue Growth
- PGEN N/A
- DCGO 64.49
- 52 Week Low
- PGEN $0.82
- DCGO $2.75
- 52 Week High
- PGEN $1.93
- DCGO $6.90
- Technical
- Relative Strength Index (RSI)
- PGEN 45.66
- DCGO 52.35
- Support Level
- PGEN $0.86
- DCGO $3.20
- Resistance Level
- PGEN $0.92
- DCGO $3.33
- Average True Range (ATR)
- PGEN 0.05
- DCGO 0.15
- MACD
- PGEN 0.01
- DCGO 0.02
- Stochastic Oscillator
- PGEN 59.31
- DCGO 80.88
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.